SOW_Pharmaceutical Reverse Distribution Services.pdf
PDF 281 KB Posted
- Attached to
- Pharmacy Reverse Distribution Service
- Solicitation number
- SS75H70926BAO_055
About this file
Statement of Work Summary: Pharmaceutical Reverse Distribution Services
This Statement of Work establishes requirements for pharmaceutical reverse distribution services for the Billings Area Indian Health Service (IHS) across multiple Montana service units. The Contractor must be a DEA-registered reverse distributor providing on-site removal and return of expired and soon-to-expire pharmaceuticals (both controlled and non-controlled substances) to authorized manufacturers or wholesalers for eligible credit. Services shall be performed three times per year at designated locations including Blackfeet Community Hospital, Crow/Northern Cheyenne Hospital, Fort Belknap Hospital, Fort Peck Service Unit facilities, and Northern Cheyenne Service Unit, with a base contract period from June 1, 2026 through May 31, 2027, followed by four optional one-year renewal periods through May 31, 2031.
The Contractor is responsible for all labor, equipment, materials, packaging, and transportation, bearing all associated costs including travel, lodging, and taxes. Key deliverables include compliant packaging materials and prepaid shipping labels, detailed inventory reports identifying all controlled substances, DEA Form 222 documentation, certificates of destruction for non-returnable items, and reconciliation documentation provided within 60 days of shipment. The Contractor must maintain strict chain-of-custody procedures for controlled substances, ensure reconciliation matches pharmacy inventory records, apply returns credit to the pharmacy prime vendor account within 120 days of return, and accept all non-returnable items including hazardous drugs for destruction at no additional charge. Invoices must be submitted electronically through the Invoicing Processing Platform (IPP) no later than the 30th workday following service delivery, with copies sent to the Contracting Officer Representative at angela.troutt@ihs.gov. All services must comply with DEA regulations, IHS Manual Section 3-7.6C, the Controlled Substances Act, and 21 CFR Parts 1300-1321, with failure to maintain compliance subject to corrective action or contract remedies.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Sources Sought.pdf | ||
| IEE Representation Form.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Statement of Work (SOW)
1. PROJECT TITLE: Pharmaceutical Reverse Distribution Services
2. BACKGROUND/PURPOSE:
The Billings Area Indian Health Service (IHS) pharmacy programs require pharmaceutical reverse distribution services to facilitate the removal and return of expired and soon-to-expire pharmaceutical products, including both controlled and non-controlled substances, to authorized manufacturers or wholesalers for eligible credit.
The Contractor must be a U.S. Drug Enforcement Administration (DEA)-registered reverse distributor. Utilization of a qualified reverse distributor minimizes financial losses associated with expired pharmaceuticals and ensures compliance with federal regulations, IHS policy, and DEA requirements governing the handling and disposition of controlled substances.
3. SCOPE:
The Contractor shall provide all labor, equipment, materials, packaging, transportation, and documentation necessary to perform on-site pharmaceutical reverse distribution services at designated Billings Area IHS pharmacy locations.
Services include, but are not limited to:
• On-site inventory of expired and soon-to-expire medications
• Secure handling and segregation of controlled and non-controlled substances
• Packaging, transportation, and return of eligible pharmaceuticals
• Processing of manufacturer or wholesaler credits, when applicable
4. APPLICABLE DOCUMENTS:
The Contractor shall comply with all applicable federal, state, and local laws, regulations, and policies, including but not limited to:
• Indian Health Service (IHS) Manual, Section 3-7.6C – Disposal of Medication
• DEA regulations governing reverse distribution
• Controlled Substances Act (21 U.S.C. §§ 801–971)
• 21 CFR Parts 1300–1321
5. CONTRACTORS RESPONSIBILITIES:
The Contractor shall provide reverse distribution services three (3) times per year.
The Contractor shall:
• Conduct on-site removal of outdated, expired, or soon-to-expire medications during scheduled visits three (3) times per year
• Provide compliant packaging materials and prepaid shipping labels for returned pharmaceuticals
• Contractor is responsible for making available to the service unit a certificate of receipt, manifest, invoice, or other suitable listing receipt for expired medications received, with the ability to specifically identify all controlled substances. Such record will be made available by the 60th day after the self-service shipment
• Accept all non-returnable items, even hazardous drugs, for destruction for no additional charge
• Apply returns credit to pharmacy prime vendor account within 120 days of return
• Be responsible for all travel, lodging, per diem, fringe benefits, Federal/State/Local taxes, plus any other cost pertinent to the performance of this contract
• Maintain strict chain-of-custody procedures for controlled substances
• Furnish complete and accurate documentation for each visit, including:
o Detailed inventory reports of all returned medications o DEA Form 222 for controlled substances, as required o Certificates of destruction or disposition, when applicable
• Ensure all services are performed by properly trained and authorized personnel
• Coordinate scheduling with the pharmacy to minimize operational disruption
Controlled Substance Reconciliation
• The Contractor shall reconcile, or assist the pharmacy in reconciling, all controlled substances transferred to the reverse distributor. This includes verification that controlled substances accepted by the Contractor match pharmacy inventory records and documentation, including DEA Form 222 or other required DEA documentation. The Contractor shall provide reconciliation documentation sufficient to support pharmacy recordkeeping and regulatory compliance.
• Reconciliation documentation for controlled substances shall be provided to the pharmacy following each on-site pickup.
6. GOVERNMENT-FURNISHED EQUIPMENT AND INFORMATION:
The Government will not furnish equipment, materials, or supplies for performance under this contract.
The Government will provide:
• Facility DEA registration number(s) as required for the lawful transfer of controlled substances
7. PLACE OF PERFORMANCE: The pharmacy reverse distributor will make three (3) on-site visits to:
Blackfeet Service Unit:
Blackfeet Community Hospital 761 Hospital Drive Browning, MT 59417
Heart Butte Health Station 81 Disney St.
Heart Butte, MT 59448
Crow Service Unit:
Crow/Northern Cheyenne Hospital 10111 South 7650 East Crow Agency, MT 59023
Lodge Grass Health Clinic 418 Harding Ave Lodge Grass, MT 59050
Pryor Health Station 2 Pryor Gap Road Pryor, MT 59066
Fort Belknap Service Unit:
Fort Belknap Hospital 670 Agency Main Street Harlem, MT 59527
Fort Peck Service Unit:
Verne E. Gibbs Health Center 108 H St E Poplar, MT 59256
Chief Redstone Clinic 550 6th Ave N Wolf Point, MT 59201
Northern Cheyenne Service Unit 420 N. Cheyenne Ave Lame Deer, MT 59044
8. PERIOD OF PERFORMANCE:
Base Period: June 1, 2026 – May 31, 2027
Option Year 1: June 1, 2027 – May 31, 2028
Option Year 2: June 1, 2028 – May 31, 2029
Option Year 3: June 1, 2029 – May 31, 2030
Option Year 4: June 1, 2030 – May 31, 2031
9. SECURITY: None.
10. QUALITY ASSURANCE:
The Contractor shall ensure all services are performed in accordance with DEA regulations and industry best practices. Failure to maintain compliance may result in corrective action or contract remedies in accordance with applicable FAR provisions.
11. INVOICE SUBMISSION AND PAYMENT:
Invoices shall be submitted through the Invoicing Processing Platform (IPP), a secure, web-based electronic invoicing system provided by the U.S. Department of the Treasury’s Bureau of the Fiscal Service, in partnership with the Federal Reserve Bank of St. Louis. The use of IPP shall take precedence over previously established invoicing procedures in accordance with HHSAR 352.232-71, Electronic Submission and Processing of Payment Requests”. The IPP website address is: https://www.ipp.gov.
Supporting documentation and invoices must be submitted no later than the 30th workday of the month after services have been provided. Changes or corrections shall be submitted by separate invoice. In addition to information required for submission of a “proper” invoice in accordance with FAR 52.212-4 (g) all invoices must include:
1. Invoice Date and Number
2. Contract Number
3. Charges for service or products identified BY LINE ITEM Number
4. Brief description of products or services rendered
5. Charges should follow Line Item structure on contract to include Quantity, Unit of Issue, Unit Price, and Total Amount as applicable
6. Dates of Service or Shipment
Invoices shall be prepared and submitted electronically and in accordance with rates and terms as stated in the contract. Invoices shall be submitted electronically in IPP through the US Treasury. Notification and a copy of the Invoice shall be submitted to:
COR: angela.troutt@ihs.gov; a copy of the invoice should be sent electronically to the COR at the address listed above.
12. CONTRACTING OFFICER AUTHORITY:
Authority to negotiate changes in the terms, conditions or amounts cited in this contract is reserved for the Contracting Officer.
mailto:angela.troutt@ihs.gov
File details come from the government source that posted it. Updated .